Browse By: Country ι Category ι Tag
Home  »  Competitive Analysis

Competitive Analysis Market Research Reports

More

Global and China Logo Industry 2014 Market Research Report
The report firstly introduced Logo basic information included Logo definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Logo industry policy and plan, Logo product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Logo capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Logo products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and China Logo capacity
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Global and China Hub Logo Industry 2014 Market Research Report
The report firstly introduced Hub Logo basic information included Hub Logo definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Hub Logo industry policy and plan, Hub Logo product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Hub Logo capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Hub Logo products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Glob
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Amazon, QVC Inc., Sears Holding Corp, Valve Corp. - Company Analysis, SWOT, Marketing Strategy
The online retail industry is one of the most progressive sectors of the United States. Online shopping has opened up huge new choices for consumers, not just in terms of what they buy, but how they buy it. The Internet has empowered the consumer in three ways: during the decision-making process leading to the purchase; at the actual moment of purchase; and throughout the product ownership period, including product delivery, maintenance, and return. The biggest player in the United States online retail market is Amazon.com and it is expected to remain a clear leader in the years to come. The other companies are however competing to grab the chunk of the pie but are way behind Amazon.com. Another online retailer QVC Inc strategy in the online retail landscape is to create a highly imme
Published Date: Aug 2013
Published By: Renub Research

Price: $750
Johnson & Johnson / Janssen Partnering 2005-2013
This report provides all the information you require to better understand Johnson & Johnson and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1&nbs
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Merck & Co Partnering 2005-2013
This report provides all the information you require to better understand Merck & Co and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 provi
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Merck KGaA / Merck Serono Partnering 2005-2013
This report provides all the information you require to better understand Merck KGaA and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 provides
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Mitsubishi Tanabe Partnering 2005-2013
This report provides all the information you require to better understand Mitsubishi Tanabe and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 pr
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Mylan Partnering 2005-2013
This report provides all the information you require to better understand Mylan and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 provides an in
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Otsuka Partnering 2005-2013
This report provides all the information you require to better understand Otsuka and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 provides an i
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Pfizer Partnering 2005-2013
This report provides all the information you require to better understand Pfizer and its partnering interests and activities over the past seven years.One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives.The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1 provides an i
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Shionogi Partnering 2005-2013
This report provides all the information you require to better understand Shionogi and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orientation of bigpharma’s dealmaking and business activities. 
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Shire Partnering 2005-2013
This report provides all the information you require to better understand Shire and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1&n
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Stada Partnering 2005-2013
This report provides all the information you require to better understand Stada and its partnering interests and activities over the past seven years.  One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapt
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Takeda Partnering 2005-2013
This report provides all the information you require to better understand Takeda and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1&
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Teva Partnering 2005-2013
This report provides all the information you require to better understand Teva and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1&nb
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
UCB Partnering 2005-2013
This report provides all the information you require to better understand UCB and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1&nbs
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Valeant Partnering 2005-2013
This report provides all the information you require to better understand Valeant and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  Chapter 1
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Warner Chilcott Partnering 2005-2013
This report provides all the information you require to better understand Warner Chilcott and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the companys business development objectives. The initial chapters of this report provide an orientation of bigpharmas dealmaking and business activities.  C
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Multiple Sclerosis Partnering 2007-2013
The Multiple Sclerosis Partnering 2007-2013 provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies . The report provides an analysis of multiple sclerosis disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors multiple sclerosis technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller compan
Published Date: Jul 2013
Published By: Current Partnering

Price: $995
Crohn\'s Disease Partnering 2007-2013
The Crohn\'s Disease Partnering 2007-2013 report provides understanding and access to the crohn\'s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in crohn\'s disease partnering deals Top crohn\'s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Crohn\'s Disease Partnering 2007-2013 provides understanding and access to the crohn\'s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of crohn\'s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors crohn\'s disease t
Published Date: Jul 2013
Published By: Current Partnering

Price: $995

Back To Top